+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Brain Cancer Drugs Market Research Reports

Recurrent Glioblastoma - Pipeline Insight, 2024 - Product Thumbnail Image

Recurrent Glioblastoma - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 200 Pages
  • Global
From
Oligodendroglioma - Pipeline Insight, 2024 - Product Thumbnail Image

Oligodendroglioma - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 60 Pages
  • Global
From
Medulloblastoma - Pipeline Insight, 2024 - Product Thumbnail Image

Medulloblastoma - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 50 Pages
  • Global
From
Neuroblastoma - Pipeline Insight, 2024 - Product Thumbnail Image

Neuroblastoma - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 80 Pages
  • Global
From
Anaplastic astrocytoma - Pipeline Insight, 2024 - Product Thumbnail Image

Anaplastic astrocytoma - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 85 Pages
  • Global
From
Recurrent anaplastic astrocytomas - Pipeline Insight, 2024 - Product Thumbnail Image

Recurrent anaplastic astrocytomas - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 40 Pages
  • Global
From
Glioblastoma - Pipeline Insight, 2024 - Product Thumbnail Image

Glioblastoma - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 440 Pages
  • Global
From
Pemetrexed + cisplatin Drug Insight and Market Forecast - 2032 - Product Thumbnail Image

Pemetrexed + cisplatin Drug Insight and Market Forecast - 2032

  • Report
  • November 2023
  • 30 Pages
  • Global
From
DELYTACT Drug Insight and Market Forecast - 2032 - Product Thumbnail Image

DELYTACT Drug Insight and Market Forecast - 2032

  • Report
  • November 2023
  • 30 Pages
  • Global
From
From
Brain Tumor Drugs Market Forecasts from 2023 to 2028 - Product Thumbnail Image

Brain Tumor Drugs Market Forecasts from 2023 to 2028

  • Report
  • November 2023
  • 140 Pages
  • Global
From
Glioblastoma Multiforme (Gbm) - Global Clinical Trials Review, 2024 - Product Thumbnail Image

Glioblastoma Multiforme (Gbm) - Global Clinical Trials Review, 2024

  • Clinical Trials
  • February 2024
  • 1378 Pages
  • Global
From
Glioblastoma Multiforme (GBM) - Competitive Landscape - Product Thumbnail Image

Glioblastoma Multiforme (GBM) - Competitive Landscape

  • Report
  • December 2023
  • 75 Pages
  • Global
From
From
From
From
From
From
Brain Tumor Therapeutics: Global Markets to 2023 - Product Thumbnail Image

Brain Tumor Therapeutics: Global Markets to 2023

  • Report
  • December 2018
  • 161 Pages
  • Global
From
Loading Indicator

The Brain Cancer Drugs market is a segment of the pharmaceutical industry that focuses on the development and sale of drugs used to treat brain cancer. Brain cancer is a type of cancer that affects the cells of the brain and can be caused by a variety of factors, including genetics, environmental exposure, and lifestyle. Brain cancer drugs are used to treat the symptoms of brain cancer, such as headaches, seizures, and nausea, as well as to slow the progression of the disease. Brain cancer drugs are typically divided into two categories: chemotherapy and targeted therapy. Chemotherapy drugs are used to kill cancer cells, while targeted therapy drugs are designed to target specific cancer cells and stop them from growing. Both types of drugs are used in combination to treat brain cancer. Some of the major companies in the Brain Cancer Drugs market include Bristol-Myers Squibb, Merck, Pfizer, Novartis, and Roche. These companies are involved in the development and sale of drugs used to treat brain cancer, as well as in the research and development of new treatments. Show Less Read more